Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts

U. Schwartz* (Heidelberg, Germany), M. Llamazares* (Heidelberg, Germany), S. Pohl (Heidelberg, Germany), M. Richter (Heidelberg, Germany), M. Schuler (Biberach, Germany), C. Keller (Biberach, Germany), V. Mijosek (Heidelberg, Germany), T. Muley (Heidelberg, Germany), K. Quast (Biberach, Germany), J. Hey (Heidelberg, Germany), C. Heußel (Heidelberg, Germany), A. Warth (Heidelberg, Germany), G. Petrosino (Heidelberg, Germany), R. Tamas (Heidelberg, Germany), D. Weichenhan (Heidelberg, Germany), B. Brors (Heidelberg, Germany), V. Benes (Heidelberg, Germany), F. Hearth (Heidelberg, Germany), D. Wyatt (Biberach, Germany), H. Stahl (Biberach, Germany), C. Plass (Heidelberg, Germany), R. Jurkowska (Heidelberg, Germany)

Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Session: Physiological and cellular mechanisms affecting pulmonary pathologies
Session type: E-poster session
Number: 2587
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Schwartz* (Heidelberg, Germany), M. Llamazares* (Heidelberg, Germany), S. Pohl (Heidelberg, Germany), M. Richter (Heidelberg, Germany), M. Schuler (Biberach, Germany), C. Keller (Biberach, Germany), V. Mijosek (Heidelberg, Germany), T. Muley (Heidelberg, Germany), K. Quast (Biberach, Germany), J. Hey (Heidelberg, Germany), C. Heußel (Heidelberg, Germany), A. Warth (Heidelberg, Germany), G. Petrosino (Heidelberg, Germany), R. Tamas (Heidelberg, Germany), D. Weichenhan (Heidelberg, Germany), B. Brors (Heidelberg, Germany), V. Benes (Heidelberg, Germany), F. Hearth (Heidelberg, Germany), D. Wyatt (Biberach, Germany), H. Stahl (Biberach, Germany), C. Plass (Heidelberg, Germany), R. Jurkowska (Heidelberg, Germany). Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts. 2587

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004

Investigation for candidate genes of glucocorticoid resistance by genome-wide gene expression profiling in animal model of asthma
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011

DNA methylation and gene expression changes in human lung fibroblasts occur already in mild COPD and progress with disease development
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018

microRNA profiling in pulmonary fibroblasts in COPD
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011

Versatile workflow for storage, characterization and celltype resolved transcriptional and epigenetic profiling of human lung samples
Source: Virtual Congress 2020 – Reflections from the Lung Science 2020 conference
Year: 2020


Versatile workflow for storage, characterization and celltype resolved transcriptional and epigenetic profiling of human lung samples
Source: ERS Lung Science Conference 2020
Year: 2020

Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

Transcriptional characterisation of human lung cells identifies novel mesenchymal lineage markers
Source: Eur Respir J, 55 (1) 1900746; 10.1183/13993003.00746-2019
Year: 2020



Identification of disease genes by expression profiling
Source: Eur Respir J 2001; 18: 882-889
Year: 2001



A large-scale genome-wide association analysis of lung function in the Chinese population identifies novel loci and highlights shared genetic aetiology with obesity
Source: Eur Respir J, 58 (4) 2100199; 10.1183/13993003.00199-2021
Year: 2021



Where next for lung cancer gene expression profiling?
Source: Eur Respir J 2007; 30: 5-6
Year: 2007


Identifying a tissue specific microRNA molecular signature in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema
Source: ERS Lung Science Conference 2016
Year: 2016

Distinct epithelial phenotypes in child allergic respiratory disease are revealed by gene expression profiling
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009

Serum microRNA signatures identified in a genome-wide profiling predict the mortality of patients with sepsis
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011


Transcriptomic and epigenetic changes in the lung of patients with severe COPD
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017

Integrated analysis of COPD gene expression data reveals specific pathway signatures
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010